The Human Positive Cofactor 4 is a Promising Chemotherapeutic Target in Lung Adenocarcinoma

Figure 7

PC4 decreases the synergistic effect of DMOG and cisplatin. (a–l) The ratio of cell viability and relative enhancement of the effect of cisplatin were calculated.  < 0.05.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)